| 2289216 | BW367_H | Body weight QTL 367 (human) | | .0469 | Body fat amount | percent fat | 19 | 10652925 | 36652925 | Human |
| 1331657 | COPD9_H | Chronic obstructive pulmonary disease QTL 9 (human) | 1.94 | | Chronic airflow obstruction | post-bronchodilator FEV1 | 19 | 12712793 | 57533128 | Human |
| 1298436 | OSTEAR8_H | Osteoarthritis QTL 8 (human) | 1.82 | | Joint/bone inflammation | hand osteoarthritis | 19 | 17417129 | 43417129 | Human |
| 1559346 | SCL94_H | Serum cholesterol level QTL 94 (human) | 1.54 | .004 | Lipid level | total cholesterol | 19 | 17417129 | 43417129 | Human |
| 1559351 | SCL93_H | Serum cholesterol level QTL 93 (human) | 2.23 | .0007 | Lipid level | LDL cholesterol | 19 | 17417129 | 43417129 | Human |
| 2293396 | PRSTS213_H | Prostate tumor susceptibility QTL 213 (human) | | .0004 | Prostate tumor susceptibility | | 19 | 17417129 | 43417129 | Human |
| 2315768 | GLUCO148_H | Glucose level QTL 148 (human) | 2.2 | .002 | Glucose level | | 19 | 18914859 | 44914859 | Human |
| 2292899 | PRSTS34_H | Prostate tumor susceptibility QTL 34 (human) | | | Prostate tumor susceptibility | late onset | 19 | 21098259 | 47098259 | Human |
| 1331666 | COPD5_H | Chronic obstructive pulmonary disease QTL 5 (human) | 3.3 | | Chronic airflow obstruction | pre-bronchodilator FEV1 | 19 | 21682674 | 53806756 | Human |
| 1357328 | AASTH24_H | Allergic/atopic asthma related QTL 24 (human) | 1.02 | | Reversible airflow obstruction | post-bronchodilator FEV1 | 19 | 29153142 | 55153142 | Human |
| 1298467 | OSTEAR9_H | Osteoarthritis QTL 9 (human) | 1.83 | | Joint/bone inflammation | hand osteoarthritis | 19 | 31405702 | 57405702 | Human |
| 1357315 | AASTH51_H | Allergic/atopic asthma related QTL 51 (human) | | .0005 | Reversible airflow obstruction | | 19 | 31405702 | 57405702 | Human |
| 1581531 | BP78_H | Blood pressure QTL 78 (human) | 2.3 | .001 | Blood pressure | pulse pressure | 19 | 31405702 | 57405702 | Human |
| 1559403 | SCL118_H | Serum cholesterol level QTL 118 (human) | 3.16 | | Lipid level | triglyceride | 19 | 31405702 | 57405702 | Human |
| 1559124 | SCL23_H | Serum cholesterol level QTL 23 (human) | 3.24 | .000617 | Lipid level | LDL cholesterol | 19 | 31405702 | 57405702 | Human |
| 2302744 | MAMTS26_H | Mammary tumor susceptibility QTL 26 (human) | | .025 | Mammary tumor susceptibility | | 19 | 31405702 | 57405702 | Human |
| 2302745 | MAMTS27_H | Mammary tumor susceptibility QTL 27 (human) | | .034 | Mammary tumor susceptibility | | 19 | 31405702 | 57405702 | Human |
| 2302750 | MAMTS28_H | Mammary tumor susceptibility QTL 28 (human) | | .054 | Mammary tumor susceptibility | | 20 | 31405702 | 57405702 | Human |
| 1559110 | SCL22_H | Serum cholesterol level QTL 22 (human) | 3.59 | .000241 | Lipid level | LDL cholesterol | 19 | 32410844 | 58410844 | Human |
| 1559230 | SAPOE1_H | Serum apolipoprotein E level QTL 1 (human) | 4.2 | | Apolipoprotein level | apolipoprotein E level | 19 | 34098157 | 57667065 | Human |
| 1300027 | BW34_H | Body weight QTL 34 (human) | 1.5 | .0063 | Body weight | body mass index | 19 | 34098361 | 41527533 | Human |
| 2316701 | GLUCO261_H | Glucose level QTL 261 (human) | 1.5 | .0063 | Glucose level | | 19 | 34098361 | 41527533 | Human |
| 2300240 | PRSTS349_H | Prostate tumor susceptibility QTL 349 (human) | | .0001 | Prostate tumor susceptibility | | 19 | 35332164 | 59110802 | Human |